Authors:
Kemper, CA
Witt, MD
Keiser, PH
Dube, MP
Forthal, DN
Leibowitz, M
Smith, DS
Rigby, A
Hellmann, NS
Lie, YS
Leedom, J
Richman, D
McCutchan, JA
Haubrich, R
Citation: Ca. Kemper et al., Sequencing of protease inhibitor therapy: insights from an analysis of HIVphenotypic resistance in patients failing protease inhibitors, AIDS, 15(5), 2001, pp. 609-615
Authors:
Petropoulos, CJ
Parkin, NT
Limoli, KL
Lie, YS
Wrin, T
Huang, W
Tian, H
Smith, D
Winslow, GA
Capon, DJ
Whitcomb, JM
Citation: Cj. Petropoulos et al., A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1, ANTIM AG CH, 44(4), 2000, pp. 920-928
Authors:
Smibert, CA
Lie, YS
Shillinglaw, W
Henzel, WJ
Macdonald, PM
Citation: Ca. Smibert et al., Smaug, a novel and conserved protein, contributes to repression of nanos mRNA translation in vitro, RNA, 5(12), 1999, pp. 1535-1547
Citation: Ys. Lie et Pm. Macdonald, Apontic binds the translational repressor Bruno and is implicated in regulation of oskar mRNA translation, DEVELOPMENT, 126(6), 1999, pp. 1129-1138
Citation: Ys. Lie et Pm. Macdonald, Translational regulation of oskar mRNA occurs independent of the cap and poly(A) tail in Drosophila ovarian extracts, DEVELOPMENT, 126(22), 1999, pp. 4989-4996
Authors:
Lau, ASL
Lie, YS
Norling, LA
Sernatinger, J
Dinowitz, M
Petropoulos, CJ
Xu, YA
Citation: Asl. Lau et al., Quantitative competitive reverse transcription-PCR as a method to evaluateretrovirus removal during chromatography procedures, J BIOTECH, 75(2-3), 1999, pp. 105-115
Authors:
Chaudry, GJ
Farrell, KB
Ting, YT
Schmitz, C
Lie, YS
Petropoulos, CJ
Eiden, MV
Citation: Gj. Chaudry et al., Gibbon ape leukemia virus receptor functions of type III phosphate transporters from CHOK1 cells are disrupted by two distinct mechanisms, J VIROLOGY, 73(4), 1999, pp. 2916-2920
Authors:
Parkin, NT
Lie, YS
Hellmann, N
Markowitz, M
Bonhoeffer, S
Ho, DD
Petropoulos, CJ
Citation: Nt. Parkin et al., Phenotypic changes in drug susceptibility associated with failure of humanimmunodeficiency virus type 1 (HIV-1) triple combination therapy, J INFEC DIS, 180(3), 1999, pp. 865-870